rs2941382
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000335388.5(LPAL2):n.850+407T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.863 in 151,794 control chromosomes in the GnomAD database, including 56,888 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.86 ( 56888 hom., cov: 31)
Consequence
LPAL2
ENST00000335388.5 intron
ENST00000335388.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.02
Publications
5 publications found
Genes affected
LPAL2 (HGNC:21210): (lipoprotein(a) like 2 (pseudogene)) Apolipoprotein(a) is the distinguishing protein moiety of lipoprotein(a), of which elevated plasma levels are correlated with an increased risk of atherosclerosis. This gene is similar to the lipoprotein, Lp(a) gene, but all transcripts produced by this gene contain a truncated open reading frame and are candidates for nonsense-mediated decay. Consequently, this gene is considered to be a pseudogene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.06).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.973 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.863 AC: 130825AN: 151676Hom.: 56824 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
130825
AN:
151676
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.863 AC: 130951AN: 151794Hom.: 56888 Cov.: 31 AF XY: 0.863 AC XY: 64019AN XY: 74164 show subpopulations
GnomAD4 genome
AF:
AC:
130951
AN:
151794
Hom.:
Cov.:
31
AF XY:
AC XY:
64019
AN XY:
74164
show subpopulations
African (AFR)
AF:
AC:
39120
AN:
41174
American (AMR)
AF:
AC:
12545
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
2871
AN:
3468
East Asian (EAS)
AF:
AC:
5144
AN:
5166
South Asian (SAS)
AF:
AC:
4317
AN:
4812
European-Finnish (FIN)
AF:
AC:
8762
AN:
10590
Middle Eastern (MID)
AF:
AC:
269
AN:
294
European-Non Finnish (NFE)
AF:
AC:
55277
AN:
68004
Other (OTH)
AF:
AC:
1840
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
882
1764
2646
3528
4410
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3291
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.